Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings
|Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings|
Joshua Richter, MD
|Release Date: August 08, 2022|
Expiration Date: August 08, 2023
Join Dr. Richter as he reviews new and noteworthy data on newly diagnosed and relapsed/refractory multiple myeloma from the American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2022 annual meetings.Provided by MediCom Worldwide, Inc.
This activity is not commercially supported
|Begin, Earn CreditView Only, No Credit|